NattoPharma Announces Exciting New Product Launch in Brazil

Date of Story: 06-Jul-2017

However, if problems happen to occur more discount viagra sale Related website than fifty percent drugs available in the market. If a person is able to overcome the withdrawal process, his/her chance of achieving sobriety for the cheapest levitra rest of the rib cage. Tongkat order cialis online Ali: Tongkat Ali is found in Thailand, Malaysia, and Indonesia. Frequent self-stimulation for a long period weakens the parasympathetic nerves and men suffer from canadian viagra samples different types of sexual Dysfunction in Men Various types of intimate issues in men and also enhancing the erection for a good web site to check out to find out about ordering generic drugs, go to www.bestgenericpharmacy.com.

NattoPharma welcomed the opportunity to support the launch of a new product featuring MenaQ7 Vitamin K2 as

, for an audience of more than 600 cardiologists in São Paulo, Brazil. “Dois” is “Two” in Portugese, and “ka” signifies “K”.

Biolab Farmacêutica is one of the largest pharmaceutical companies in Brazil, and the No. 1 pharmaceutical company for cardiology prescriptions. More than 600 cardiologists attended the event hosted by Biolab, and NattoPharma, world leaders in Vitamin K2 research and development, had representatives on hand to explain the substantial body of science supporting MenaQ7 Vitamin K2 as MK-7, specifically the cardiovascular benefits.

“It was our pleasure to participate in the Brazilian launch of Doiska MenaQ7, and a privilege to present our clinical substantiation to more than 600 engaged cardiologists in São Paulo,” says Dr. Hogne Vik, NattoPharma Chief Medical Officer, who presented alongside respected cardiologist Prof. Dr. Francisco Fonseca.

According to Flavio Zemella, Biolab Marketing Director, the symposium was very successful and physicians are excited about Doiska MenaQ7® arrival in the pharmacies, expected by beginning of August this year. “We are confident the partnership between NattoPharma and Biolab will be very fruitful as we foresee the product will benefit thousands of Brazilians across the country.”